G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn… Read more
G Medical Innovations Holdings Ltd (GMVDF) - Total Liabilities
Latest total liabilities as of March 2023: $9.40 Million USD
Based on the latest financial reports, G Medical Innovations Holdings Ltd (GMVDF) has total liabilities worth $9.40 Million USD as of March 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
G Medical Innovations Holdings Ltd - Total Liabilities Trend (2015–2022)
This chart illustrates how G Medical Innovations Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
G Medical Innovations Holdings Ltd Competitors by Total Liabilities
The table below lists competitors of G Medical Innovations Holdings Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CRBAF
PINK:CRBAF
|
USA | $6.94 Million |
|
musicMagpie PLC
LSE:MMAG
|
UK | GBX28.30 Million |
|
Eagle Royalties Ltd.
OTCGREY:ERYTF
|
USA | $107.74K |
|
Third Bench Inc.
PINK:THBD
|
USA | $2.96 Million |
|
Lead Data Inc
TW:2443
|
Taiwan | NT$55.01 Million |
Liability Composition Analysis (2015–2022)
This chart breaks down G Medical Innovations Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.95 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how G Medical Innovations Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for G Medical Innovations Holdings Ltd (2015–2022)
The table below shows the annual total liabilities of G Medical Innovations Holdings Ltd from 2015 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $9.40 Million | -29.51% |
| 2021-12-31 | $13.33 Million | +58.70% |
| 2020-12-31 | $8.40 Million | -54.96% |
| 2019-12-31 | $18.65 Million | +11.21% |
| 2018-12-31 | $16.77 Million | +102.15% |
| 2017-12-31 | $8.29 Million | +197.85% |
| 2016-12-31 | $2.78 Million | +69.69% |
| 2015-12-31 | $1.64 Million | -- |